1. Ketamine* Journal of Pain and Symptom Management
Rachel Quibell, MRCGP, Eric E. Prommer, MD, Mary Mihalyo, BS, PharmD, RPh, Robert Twycross, DM, FRCP, Andrew Wilcock, DM, FRCP 
Journal of Pain and Symptom Management 
Volume 41, Issue 3, Pages (March 2011)
DOI: /j.jpainsymman
Copyright © Terms and Conditions

2. Figure
Diagram of NMDA (excitatory) receptor-channel complex. The channel is blocked by Mg2+ when the membrane potential is at its resting level (voltage-dependent block) and by drugs that act at the phencyclidine (PCP) binding site in the glutamate-activated channel, e.g., dextromethorphan, ketamine, methadone (use-dependent block).4 Figure reproduced by permission of palliativedrugs.com Ltd.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © Terms and Conditions